Table 1. Genes and samples screened.
|
Samples |
||||
|---|---|---|---|---|
| SCZ | ASD | Controls QNTS | Controls | |
| GRIN1 | 429 subjects (292 trios) | 142 trios | 285 trios | Not analyzed |
| GRIN2A | 429 subjects (292 trios) | 142 trios | Not analyzed | 283 subjects |
| GRIN2B | 429 subjects (292 trios) | 428 subjects (404 trios) | Not analyzed | 283 subjects |
| GRIN2C | 429 subjects (292 trios) | 428 subjects (404 trios) | 285 trios | 283 subjects |
| GRIN2D | 429 subjects (292 trios) | 142 trios | Not analyzed | 283 subjects |
| GRIN3A | 429 subjects (292 trios) | 142 trios | 285 trios | 283 subjects |
| GRIN3B | 429 subjects (292 trios) | 428 subjects (404 trios) | Not analyzed | Not analyzed |
Abbreviations: ASD, autism spectrum disorders; SCZ, schizophrenia; QNTS, Quebec Newborn Twin Study.
Number of trios indicates individuals having parental DNA from both parents available.